US Stock MarketDetailed Quotes

ARTV Artiva Biotherapeutics

Watchlist
  • 10.630
  • -0.330-3.01%
Trading Dec 26 14:28 ET
258.20MMarket Cap-4.21P/E (TTM)

Artiva Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
-74.62%251K
579.21%33.49M
2.35M
26.66M
0
-26.63%989K
146.30%4.93M
1,114.41%1.35M
Operating revenue
--0
--0
--0
567.67%32.92M
--1.78M
--26.66M
--0
-26.63%989K
146.30%4.93M
1,114.41%1.35M
Cost of revenue
Gross profit
Operating expense
15.71%18.34M
5.67%16.19M
-21.06%14.74M
-0.92%64.16M
14.32M
15.85M
15.32M
38.64%18.68M
17.16%64.76M
-44.51%13.47M
Selling and administrative expenses
73.06%4.81M
-4.98%3.86M
-8.17%3.59M
-33.04%13.91M
--3.17M
--2.78M
--4.06M
3.69%3.91M
61.50%20.78M
41.78%3.77M
-General and administrative expense
73.06%4.81M
-4.98%3.86M
-8.17%3.59M
-33.04%13.91M
--3.17M
--2.78M
--4.06M
3.69%3.91M
61.50%20.78M
41.78%3.77M
Research and development costs
3.51%13.52M
9.51%12.33M
-24.47%11.16M
14.25%50.25M
--11.15M
--13.07M
--11.26M
52.20%14.77M
3.71%43.98M
-55.12%9.71M
Operating profit
-269.60%-18.34M
-5.67%-16.19M
18.07%-14.49M
48.74%-30.67M
-11.97M
10.81M
-15.32M
-45.89%-17.69M
-12.31%-59.83M
49.84%-12.12M
Net non-operating interest income expense
341.63%1.85M
-32.81%-676K
-36.52%650K
95.90%2.54M
583K
418K
-509K
1.02M
1.29M
Non-operating interest income
341.63%1.85M
-32.81%-676K
-36.52%650K
95.90%2.54M
--583K
--418K
---509K
--1.02M
--1.29M
----
Other net income (expense)
-2,066.00%-983K
7,612.90%2.33M
-128.30%-121K
156.00%512K
485K
50K
-31K
-53K
101.08%200K
Gain on sale of security
---977K
--2.35M
---268K
--707K
----
----
----
----
----
----
Other non- operating income (expenses)
-112.00%-6K
25.81%-23K
377.36%147K
-197.50%-195K
---222K
--50K
---31K
---53K
101.08%200K
----
Income before tax
-254.91%-17.47M
8.35%-14.54M
16.47%-13.96M
52.65%-27.62M
-10.9M
11.28M
-15.86M
-37.88%-16.72M
18.78%-58.34M
71.62%-12.12M
Income tax
35.85%72K
53K
Net income
-254.91%-17.47M
8.35%-14.54M
16.47%-13.96M
52.57%-27.7M
-10.97M
11.28M
-15.86M
-37.88%-16.72M
18.71%-58.39M
71.62%-12.12M
Net income continuous Operations
-254.91%-17.47M
8.35%-14.54M
16.47%-13.96M
52.57%-27.7M
---10.97M
--11.28M
---15.86M
-37.88%-16.72M
18.71%-58.39M
71.62%-12.12M
Minority interest income
Net income attributable to the parent company
-254.91%-17.47M
8.35%-14.54M
16.47%-13.96M
52.57%-27.7M
-10.97M
11.28M
-15.86M
-37.88%-16.72M
18.71%-58.39M
71.62%-12.12M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-254.91%-17.47M
8.35%-14.54M
16.47%-13.96M
52.57%-27.7M
-10.97M
11.28M
-15.86M
-37.88%-16.72M
18.71%-58.39M
71.62%-12.12M
Basic earnings per share
-176.36%-0.92
63.15%-0.6244
16.56%-1.49
50.78%-3.07
-0.4714
1.2048
-1.6943
-37.88%-1.7857
18.71%-6.237
71.62%-1.2951
Diluted earnings per share
-176.36%-0.92
63.15%-0.6244
16.56%-1.49
50.78%-3.07
-0.4714
1.2048
-1.6943
-37.88%-1.7857
18.71%-6.237
71.62%-1.2951
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q1)Mar 31, 2022
Total revenue 00-74.62%251K579.21%33.49M2.35M26.66M0-26.63%989K146.30%4.93M1,114.41%1.35M
Operating revenue --0--0--0567.67%32.92M--1.78M--26.66M--0-26.63%989K146.30%4.93M1,114.41%1.35M
Cost of revenue
Gross profit
Operating expense 15.71%18.34M5.67%16.19M-21.06%14.74M-0.92%64.16M14.32M15.85M15.32M38.64%18.68M17.16%64.76M-44.51%13.47M
Selling and administrative expenses 73.06%4.81M-4.98%3.86M-8.17%3.59M-33.04%13.91M--3.17M--2.78M--4.06M3.69%3.91M61.50%20.78M41.78%3.77M
-General and administrative expense 73.06%4.81M-4.98%3.86M-8.17%3.59M-33.04%13.91M--3.17M--2.78M--4.06M3.69%3.91M61.50%20.78M41.78%3.77M
Research and development costs 3.51%13.52M9.51%12.33M-24.47%11.16M14.25%50.25M--11.15M--13.07M--11.26M52.20%14.77M3.71%43.98M-55.12%9.71M
Operating profit -269.60%-18.34M-5.67%-16.19M18.07%-14.49M48.74%-30.67M-11.97M10.81M-15.32M-45.89%-17.69M-12.31%-59.83M49.84%-12.12M
Net non-operating interest income expense 341.63%1.85M-32.81%-676K-36.52%650K95.90%2.54M583K418K-509K1.02M1.29M
Non-operating interest income 341.63%1.85M-32.81%-676K-36.52%650K95.90%2.54M--583K--418K---509K--1.02M--1.29M----
Other net income (expense) -2,066.00%-983K7,612.90%2.33M-128.30%-121K156.00%512K485K50K-31K-53K101.08%200K
Gain on sale of security ---977K--2.35M---268K--707K------------------------
Other non- operating income (expenses) -112.00%-6K25.81%-23K377.36%147K-197.50%-195K---222K--50K---31K---53K101.08%200K----
Income before tax -254.91%-17.47M8.35%-14.54M16.47%-13.96M52.65%-27.62M-10.9M11.28M-15.86M-37.88%-16.72M18.78%-58.34M71.62%-12.12M
Income tax 35.85%72K53K
Net income -254.91%-17.47M8.35%-14.54M16.47%-13.96M52.57%-27.7M-10.97M11.28M-15.86M-37.88%-16.72M18.71%-58.39M71.62%-12.12M
Net income continuous Operations -254.91%-17.47M8.35%-14.54M16.47%-13.96M52.57%-27.7M---10.97M--11.28M---15.86M-37.88%-16.72M18.71%-58.39M71.62%-12.12M
Minority interest income
Net income attributable to the parent company -254.91%-17.47M8.35%-14.54M16.47%-13.96M52.57%-27.7M-10.97M11.28M-15.86M-37.88%-16.72M18.71%-58.39M71.62%-12.12M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -254.91%-17.47M8.35%-14.54M16.47%-13.96M52.57%-27.7M-10.97M11.28M-15.86M-37.88%-16.72M18.71%-58.39M71.62%-12.12M
Basic earnings per share -176.36%-0.9263.15%-0.624416.56%-1.4950.78%-3.07-0.47141.2048-1.6943-37.88%-1.785718.71%-6.23771.62%-1.2951
Diluted earnings per share -176.36%-0.9263.15%-0.624416.56%-1.4950.78%-3.07-0.47141.2048-1.6943-37.88%-1.785718.71%-6.23771.62%-1.2951
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Lennar Corp
LEN
+1.04%
D.R. Horton
DHI
+0.79%
Adobe
ADBE
+0.66%
Petroleo Brasileiro SA Petrobras
PBR
+0.38%
Oracle
ORCL
+0.33%

Unlock the Full List

Investment Theme Recent IPOs
Recent IPOs
Intraday+0.57%